Ulrike Röhn

Title: Ulrike Röhn: Innovator in Pharmaceutical Chemistry

Introduction

Ulrike Röhn is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of eight patents. Her work primarily focuses on developing compounds that have potential applications in treating various diseases, particularly cancer.

Latest Patents

Among her latest patents, Röhn has developed 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides. This invention encompasses compounds that can be utilized in pharmaceutical compositions for the treatment or prevention of diseases, especially those related to cancer and dysregulated immune responses. Another notable patent includes 2-phenylpyrimidine-4-carboxamides, which serve as AHR inhibitors. These compounds also have significant implications for treating similar health conditions.

Career Highlights

Röhn has had a distinguished career, working with renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical development and innovation.

Collaborations

Ulrike Röhn has collaborated with notable colleagues, including Ilona Gutcher and Ludwig Zorn. These partnerships have contributed to her success in advancing her research and patent applications.

Conclusion

Ulrike Röhn's innovative work in pharmaceutical chemistry has led to the development of several important patents that hold promise for treating critical health issues. Her contributions continue to impact the field positively.